Crescent Capital BDC (CCAP) had its price target lowered by Keefe, Bruyette & Woods from $15.50 to $15.00. They now have an "outperform" rating on the stock.
Buy These 2 SBIC & Commercial Finance Stocks Despite Industry Weakness [Yahoo! Finance]
Crescent Capital BDC (CCAP) is now covered by B. Riley Financial, Inc.. They set a "neutral" rating and a $13.50 price target on the stock.
Crescent Capital BDC (CCAP) Could Find a Support Soon, Here's Why You Should Buy the Stock Now [Yahoo! Finance]
Crescent Capital BDC - Interesting, But No Rush [Seeking Alpha]